Shanghai Shen Lian Biomedical Corp banner

Shanghai Shen Lian Biomedical Corp
SSE:688098

Watchlist Manager
Shanghai Shen Lian Biomedical Corp Logo
Shanghai Shen Lian Biomedical Corp
SSE:688098
Watchlist
Price: 8.29 CNY 4.41% Market Closed
Market Cap: ¥3.4B

Profitability Summary

Shanghai Shen Lian Biomedical Corp's profitability score is 35/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score
35/100
Profitability
Score

Margins

Earnings Waterfall
Shanghai Shen Lian Biomedical Corp

Margins Comparison
Shanghai Shen Lian Biomedical Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Shanghai Shen Lian Biomedical Corp
SSE:688098
3.4B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
853.2B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
566.5B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
243.4B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
288B USD
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.2B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
225.4B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.3B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
115.5B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Shanghai Shen Lian Biomedical Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Shanghai Shen Lian Biomedical Corp
SSE:688098
3.4B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
853.2B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
566.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
243.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
288B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.2B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
225.4B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.3B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
115.5B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Shanghai Shen Lian Biomedical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett